# Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach

> **NCT00004127** · PHASE2 · COMPLETED · sponsor: **University of Chicago** · enrollment: 35 (actual)

## Conditions studied

- Esophageal Cancer
- Gastric Cancer

## Interventions

- **DRUG:** FOLFOX regimen
- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00004127
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** 2002-10
- **Final completion:** 2003-08
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2013-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004127, "Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00004127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*